Sonovue improves endocardial border detection and variability in assessing wall motion score and ejection fraction during stress echocardiography

Irish Journal of Medical Science

Volumn 173, Issue 1, 2004, Pages 13-17

  Brown, Angie S ^a   Calachanis, M ^b   Evdoridis, C ^b   Hancock, J ^c   Wild, S ^d   Prasan, A ^c   Nihoyannopoulos, P ^b   Monaghan, M J ^c  

^a BEAUMONT HOSPITAL   (Ireland)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARBUTAMINE; CONTRAST MEDIUM; SONOVUE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG INFUSION; ENDOCARDIUM; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE WALL MOTION; HUMAN; IMAGE ANALYSIS; MALE; OBSERVER VARIATION; REST; SCORING SYSTEM; STATISTICAL ANALYSIS; STRESS ECHOCARDIOGRAPHY;

EID: 3042530236     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02914516     Document Type: Article

References (13)

1. Cohen JL, Greene TO, Ottenweller J et al. Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol 1991; 67: 1311-8.
2. Sawada SG, Segar DS, Ryan T et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83: 1605-14.
3. Sicari R, Picano E, Landi P et al. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Co-operative (EDIC) Study. J Am Coll Cardiol 1997; 2: 254-60.
4. Freeman AP, Giles RV, Walsh WF et al. Regional left ventricular wall motion assessment: comparison of two-dimensional echocardiography and radionucleide angiography with contrast angiography in healed myocardial infarction. Am J Cardiol 1985; 56: 8-12.
5. Crouse IJ, Cheirif J, Hanley DE et al. Opacification and border delineation improvement in patients with suboptimal endocardial border delineation in routine echocardiography: results of the phase III Albunex multicenter trial. J Am Coll Cardiol 1993; 22: 1494-500.
6. Falcone RA, Marcovitz PA, Perez JE et al. Intravenous albunex during dobutamine stress echocardiography: Enhanced localisation of left ventricular endocardial borders. Am Heart J 1995; 130: 254-8.
7. a during dobutamine stress echocardiography. Coronary Artery Disease 1998; 9: 567-76.
8. Feinstein S B et al. Safety and efficacy of a new trans pulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol 1990: 16: 316-24.
9. Fritzsch T et al. Sh U 508, A transpulmonary echocontrast agent. Invest Radiol 1990; 25: 5160-1.
10. Schneider M, Arditi M, Barran MB et al. BR1: a new ultrasonographic contrast agent based on sulfur hexaflouride-fifled microbubbles. Invest Radiol 1995; 8: 451-7.
11. Senior R, Kaul S, Soman P et al. Assessment of myocardial perfusion during intravenous BR-1 and harmonic power Doppler imaging. Eur Heart J 1998; 937.
12. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantification of the left ventricle by two dimensional echocardiography. Am Soc Echocardiography 1989; 2: 358-67.
13. Colon PJ, Richards DR, Moreno CA, Mutgo JP, Cheirif J. Benefits of reducing the cardiac cycle-triggering frequency of ultrasound imaging to increase myocardial opacification with FSO69 during fundamental and second harmonic imaging. J Am Soc Echocard 1997; 10: 602-7.